Results 131 to 140 of about 110,913 (253)

Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review. [PDF]

Cureus
Dasgupta S.
europepmc   +1 more source

Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors

Advanced Science, EarlyView.
Schematic illustration of the “pro‐ATO”/allicin liposomal strategy. Liposomal encapsulation improves the stability and bioavailability of both agents while masking allicin's odor. Upon release in the tumor microenvironment, ATO reactivates structural p53 mutants, and allicin inhibits ATR signaling while releasing H2S, collectively inducing synthetic ...
Xiaoling Xu, WeiYi Cheng, Menghang Yang, Li He, WeiYe Ren, JingQuan Chen, LiTing He, Dandan Bao, Zhihong Zhu, Lixin Wang, Qinghua Yao, Ji‐Gang Piao   +11 more
wiley   +1 more source

Interventions in Primary Care to Improve Cervical Cancer Screening: A Systematic Review. [PDF]

Cureus
Ahmed AE, Hatan WM, Alrehaili SE, Alghamdi WR, Altarif HK, Alotaibi GS, Alkhamis HY, Alfaya RF, Mejamemi HA, Aljasas HI.   +9 more
europepmc   +1 more source

Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis

Advanced Science, EarlyView.
This study highlights that radioimmunotherapy drives crosstalk between fibroblasts and immune cells (especially macrophages) in the cardiac microenvironment, with IL‐6 as the key mediator, and tocilizumab alleviates cardiac fibrosis by targeting this interplay.
Yuxi Luo, Ying Yu, Zhimin Zeng, Yanxin Chen, Yali Yi, Zhiqin Lu, Fujuan Zeng, Peng Xu, Daya Luo, Leifeng Chen, Anwen Liu   +10 more
wiley   +1 more source

Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review. [PDF]

Diagnostics (Basel)
Gisca T, Matasariu DR, Ursache A, Socolov DG, Scripcariu IS, Fudulu A, Anton ET, Botezatu A.   +7 more
europepmc   +1 more source

ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC‐I Antigen Presentation That Promotes Tumor Immune Evasion

Advanced Science, EarlyView.
ZBTB21 is a transcription factor that epigenetically suppresses pyroptosis and MHC‐I antigen presentation, enabling tumor immune evasion. Genetic ablation of ZBTB21 activates pyroptotic cell death and enhances antigen presentation, recruiting CD8+ T cells to overcome immune checkpoint blockade resistance.
Lei Zhao, Linlin Sheng, Jianhao Qiu, Junjie Ma, Kai Jin, Binggong Zhao, Tianrun Miao, Jing Chen, Yehong Li, Zhan Zhang, Dongfeng Sun, Yongmeng Li, Hui Tian   +12 more
wiley   +1 more source

Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study. [PDF]

Health Sci Rep
Kyei-Arthur F, Agyekum MW, Afrifa-Anane GF, Alhassan N, Kugbey N, Nyarko KM.   +5 more
europepmc   +1 more source

Cervical cancer screening

, 2009
In Hong Kong, cervical cancer is the 4th commonest malignancy in females. Cervical cytology screening is effective in reducing the incidence and mortality of cervical cancer. Women should have regular cervical smears from the time they start to have sexual activity until they reach the age of 65.
Ngan, HYS, Tam, KF
openaire   +1 more source

Multimodal AI‐Driven Identification of Dehydrocostus Lactone as a Potent Renal Fibrosis Attenuator Targeting IQGAP1

Advanced Science, EarlyView.
Renal fibrosis, a hallmark of CKD, lacks effective treatments. Herein, we developed a multimodal AI model (TCM‐SPred) to identify anti‐fibrotic agents and found that dehydrocostus lactone (DCL) targets IQGAP1 to inhibit Wnt signaling, blocking the interaction between IQGAP1 and CCT3, demonstrating potent anti‐fibrotic activity in vitro and in vivo ...
Weijiang Lin, Wenzhuo Xu, Kang Liu, Ping Wang, Zhenzhen Zhu, Wenyu Lu, Zhe Zheng, Xiaoqian Peng, Xunkai Yin, Shulan Mei, An Pan, Jian Liu, Lihong Hu   +12 more
wiley   +1 more source

Contemporary Status and Frontiers of Cervical Cancer Screening in the United States. [PDF]

Cancer Prev Res (Phila)
Eli AV, Kasten BB, Mayer CM, Samant R, Hartman YE, Chaudhary I, Imran N, Dal Zotto VL, Kahn AG, Arend RC, Warram JM.   +10 more
europepmc   +1 more source